Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772874 · ClinicalTrials.gov registry record
Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders
A clinical trial of Fecal Incontinence, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT02772874: Completed study of Fecal Incontinence, sponsored by University of Pennsylvania.
NCT02772874 is a study of Fecal Incontinence that has completed, run by University of Pennsylvania. The registered enrollment target is 21 participants, below the 334-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02772874, a study of Fecal Incontinence, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Fecal incontinence (FI) is clinically subtyped as urge FI and passive FI based on symptoms, however the pathophysiologic significance of this subtyping is not known. FI is commonly encountered in women with pelvic floor disorders. This study aims to compare characteristics of clinical severity, quality of life, anatomy, and physiology of urge FI versus passive FI. Urogynecology patients greater than age 18 with FI at least monthly over the last 3 months will be recruited for participation. Participants will be divided into urge FI subtype and passive FI subtype. Participants will complete validated questionnaires on clinical severity and quality of life, both as related to FI and general heath. Participants will undergo pelvic examination, endoanal ultrasound and anorectal manometry for evaluation of anatomic and physiologic pathology. Results between both groups will be compared. The investigators hypothesize that clinical, anatomic, and physiologic characteristics differ between urge-predominant fecal incontinence and passive-predominant fecal incontinence in women with pelvic floor disorders.
Primary Outcome
Vaizey score range 0 to 24
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Pennsylvania
- University of Pennsylvania, Division of Urogynecology - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-07-01 |
What the finished NCT02772874 record still lists
NCT02772874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 334-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Fecal Incontinence appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT02772874 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02772874 about?
NCT02772874 is a clinical study titled "Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders". Fecal incontinence (FI) is clinically subtyped as urge FI and passive FI based on symptoms, however the pathophysiologic significance of this subtyping is not known. FI is commonly encountered in women with pelvic floor disorders. This study aims to compare characteristics of clinical severity, qual...
What is the current status of trial NCT02772874?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2014-06. Estimated completion is 2016-07-01.
What conditions does trial NCT02772874 study?
This clinical trial studies the following conditions: Fecal Incontinence.
What interventions are being tested in trial NCT02772874?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02772874?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02772874 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fecal Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02772874's enrollment target sits among peer trials
21 18th of 22 higher than 5 of 22 other Fecal Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fecal Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Mechanisms of Improving Fecal Continence Muscles Motor Function
RECRUITING · NA
-
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
RECRUITING · NA
-
Autologous Muscle Fiber Fragment Injections
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia